Enhanced anti-tumor immune responses and delay of tumor development in human epidermal growth factor receptor 2 mice immunized with an immunostimulatory peptide in poly(D,L-lactic-co-glycolic) acid nanoparticles nanoparticles

Conclusion:
Taken together these findings demonstrate that the delivery of the immunostimulatory peptide Hp91 inside PLGA-NPs enhances the potency of the peptide and efficacy of a breast cancer vaccine.

Source: Breast Cancer Research - March 31, 2015 Category: Cancer & Oncology Authors: Diahnn CampbellRebecca SaenzIla BharatiDaniel SeibleLiangfang ZhangSadik EsenerBradley MessmerMarie LarssonDavorka Messmer Source Type: research